Have any questions? 706-721-6582 or cts@augusta.edu
This study is designed for patients currently being followed in another GSK study, called LATTE, to go into when LATTE finishes. Those patients will have the choice to receive the same oral drug they were getting in LATTE, or switch to the new injection medication that is being studied, to treat their HIV.